z-logo
open-access-imgOpen Access
Rapid progressive vaccine-induced immune thrombotic thrombocytopenia with cerebral venous thrombosis after ChAdOx1 nCoV-19 (AZD1222) vaccination: A case report
Author(s) -
Shin-Kuang Jiang,
WeiLiang Chen,
Chun Ru Chien,
Chi-Syuan Pan,
Sheng-Ta Tsai
Publication year - 2022
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v10.i26.9462
Subject(s) - medicine , headaches , magnetic resonance imaging , thrombus , thrombosis , venous thrombosis , stroke (engine) , surgery , radiology , mechanical engineering , engineering
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare and potentially life-threatening condition after receiving coronavirus disease vaccines. It is characterized by symptom onset at 5 to 30 d postvaccination, thrombocytopenia, thrombosis, high D-dimer level, and antiplatelet factor 4 (anti-PF4) antibody positivity. VITT can progress very fast, requiring urgent management. Only few studies have described its detailed clinical course and imaging changes. We report a typical VITT case in a patient who underwent regular repeated brain imaging examinations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here